Literature DB >> 29714008

An Introduction to Epitope Mapping.

Johan Nilvebrant1,2, Johan Rockberg3.   

Abstract

Antibodies are protein molecules used routinely for therapeutic, diagnostic, and research purposes due to their exquisite ability to selectively recognize and bind a given antigen. The particular area of the antigen recognized by the antibody is called the epitope, and for proteinaceous antigens the epitope can be of complex nature. Information about the binding epitope of an antibody can provide important mechanistic insights and indicate for what applications an antibody might be useful. Therefore, a variety of epitope mapping techniques have been developed to localize such regions. Although the real picture is even more complex, epitopes in protein antigens are broadly grouped into linear or discontinuous epitopes depending on the positioning of the epitope residues in the antigen sequence and the requirement of structure. Specialized methods for mapping of the two different classes of epitopes, using high-throughput or high-resolution methods, have been developed. While different in their detail, all of the experimental methods rely on assessing the binding of the antibody to the antigen or a set of antigen mimics. Early approaches utilizing sets of truncated proteins, small numbers of synthesized peptides, and structural analyses of antibody-antigen complexes have been significantly refined. Current state-of-the-art methods involve combinations of mutational scanning, protein display, and high-throughput screening in conjunction with bioinformatic analyses of large datasets.

Keywords:  Antibody; Antigen; Epitope; Epitope mapping; Mutagenesis; Peptide; Prediction; Structural biology

Mesh:

Substances:

Year:  2018        PMID: 29714008     DOI: 10.1007/978-1-4939-7841-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Computational epitope binning reveals functional equivalence of sequence-divergent paratopes.

Authors:  Jarjapu Mahita; Dong-Gun Kim; Sumin Son; Yoonjoo Choi; Hak-Sung Kim; Chris Bailey-Kellogg
Journal:  Comput Struct Biotechnol J       Date:  2022-04-30       Impact factor: 6.155

2.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05

3.  Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor.

Authors:  Joey Sheff; Ping Wang; Ping Xu; Melanie Arbour; Luke Masson; Henk van Faassen; Greg Hussack; Kristin Kemmerich; Eric Brunette; Danica Stanimirovic; Jennifer J Hill; John Kelly; Feng Ni
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.996

4.  Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody.

Authors:  Arthur J Schick; Victor Lundin; Justin Low; Kun Peng; Richard Vandlen; Aaron T Wecksler
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 5.  Epitope mapping of neutralising anti-SARS-CoV-2 monoclonal antibodies: Implications for immunotherapy and vaccine design.

Authors:  Somayeh Ghotloo; Faezeh Maghsood; Forough Golsaz-Shirazi; Mohammad Mehdi Amiri; Christiane Moog; Fazel Shokri
Journal:  Rev Med Virol       Date:  2022-04-08       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.